Samsung Research disclosed two new on-device AI foundation models, xMAE and HiMAE, that analyze wearable heart, sleep and activity biosignals locally on a smartwatch without cloud processing, though both remain research projects without a release date.
Johns Hopkins researchers reported July 31, 2026 that their AI-powered DELFI liquid biopsy blood test detected liver cancer consistently across 377 patients from Guatemala and Romania, two populations with very different disease pathways.
A whistleblower lawsuit filed July 6, 2026 alleges Mayo Clinic staff concealed a 67% error rate in its internally built AI assistant MAYA and retaliated against the former research operations director who raised the concern.
MMRO announced September 4, 2026 that it earned URAC's Artificial Intelligence in Health Care Accreditation, becoming one of the first independent medical review organizations certified under the year-old voluntary AI governance program.
A Florida hospital faces a lawsuit alleging an AI diagnostic tool's low-risk flag delayed a patient's cancer diagnosis, raising new liability questions for hospitals and vendors deploying clinical AI tools.
Chai Discovery closed a $400 million Series C at a $3.8 billion valuation, tripling its price tag in seven months, as OpenAI, Eli Lilly, and Index Ventures back its AI-driven antibody design platform.
Germany's nationwide PRAIM study found AI-assisted mammogram reading raised the breast-cancer detection rate by 17.6%, adding to a wave of 2026 studies from Sweden and South Korea supporting AI as a screening aid.
Slingshot AI withdrew its Ash therapy chatbot from the UK in January 2026, citing unclear medical-device regulations, spotlighting the growing legal gray zone around AI mental-health apps.
University of Pennsylvania researchers built ApexGO, a generative AI system that redesigns weak antibiotic peptide candidates, and two of its AI-optimized molecules matched last-resort antibiotic polymyxin B in mouse infection tests, according to a study published in Nature Machine Intelligence.
New data presented at the American Heart Association's International Stroke Conference show Viz.ai's care-coordination platform cut door-in-door-out times for large vessel occlusion stroke patients by 44% at Adventist Health plus Rideout, nearly a 90-minute improvement over historical performance.